Le Bail J C, Varnat F, Nicolas J C, Habrioux G
UPRES EA 1085, Laboratoire de Biochimie, Faculté de Pharmacie, Limoges, France.
Cancer Lett. 1998 Aug 14;130(1-2):209-16. doi: 10.1016/s0304-3835(98)00141-4.
The interaction between the estrogen receptor and a variety of flavonoids was studied in the presence or absence of estradiol using a stably-transfected human breast cancer cell line (MVLN). On the other hand, flavonoids were evaluated for their effects on proliferation in estrogen-dependent (MCF-7) and independent (MDA-MB231) human breast cancer cells. We established a relationship structure-activity and determined regions and/or substituents essential for estrogenic or antiestrogenic activities. In contrast, we did not find the same relationship for cell proliferation. Among all flavonoids used, only 7-methoxyflavanone and 7,8-dihydroxyflavone at high concentrations (50 microM) possess antiestrogenic and antiproliferative activities. These results suggest that two hydroxyls (in positions 7 and 8) or 7-methoxy substituents are essential for the antiestrogenic activity of flavonoids. However, it seems that flavonoids at high concentrations exert their antiproliferative activity through other estrogen receptor-independent mechanisms.
使用稳定转染的人乳腺癌细胞系(MVLN),在有或没有雌二醇存在的情况下,研究了雌激素受体与多种黄酮类化合物之间的相互作用。另一方面,评估了黄酮类化合物对雌激素依赖性(MCF-7)和非依赖性(MDA-MB231)人乳腺癌细胞增殖的影响。我们建立了结构-活性关系,并确定了对雌激素或抗雌激素活性至关重要的区域和/或取代基。相比之下,我们未发现细胞增殖存在相同的关系。在所有使用的黄酮类化合物中,只有高浓度(50 microM)的7-甲氧基黄酮和7,8-二羟基黄酮具有抗雌激素和抗增殖活性。这些结果表明,两个羟基(7位和8位)或7-甲氧基取代基对黄酮类化合物的抗雌激素活性至关重要。然而,高浓度的黄酮类化合物似乎通过其他与雌激素受体无关的机制发挥其抗增殖活性。